Skip to Content

Pure Harvest Corporate Group Inc PHCG

Morningstar Rating
$0.00 0.00 (27.27%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHCG is trading at a 55% discount.
Price
$0.00
Fair Value
$2.45
Uncertainty
Extreme
1-Star Price
$5.58
5-Star Price
$5.53
Economic Moat
Kchc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHCG is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.00
Market Cap
$193,459.41
Volume/Avg
435,000 / 271,379

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pure Harvest Corporate Group Inc manufactures, distributes, and sells a wide range of cannabis products including hemp, CBD, and marijuana, THC consumer products. The company's THC product line includes bulk flowers, pre-rolls, and THC concentrates. It also sells THC distillate as an ingredient or raw material to other licensed marijuana infused products manufacturers within the State of Colorado along with wholesale THC concentrates such as wax and shatter.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
25

Valuation

Metric
PHCG
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PHCG
Quick Ratio
0.40
Current Ratio
0.64
Interest Coverage
−1.30
Quick Ratio
PHCG

Profitability

Metric
PHCG
Return on Assets (Normalized)
−94.62%
Return on Equity (Normalized)
−6,183.09%
Return on Invested Capital (Normalized)
−73.81%
Return on Assets
PHCG
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRJqbsrlmvXtsyhm$70.9 Bil
ZTS
Zoetis Inc Class AYflpchcwcVwn$68.9 Bil
HLN
Haleon PLC ADRPwdzktbffNbv$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRXgrxzlgbTwrbg$14.7 Bil
VTRS
Viatris IncWwsljyyxDvpb$13.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVkbbndzDcq$11.9 Bil
CTLT
Catalent IncYglkyrmPcwlch$10.1 Bil
PRGO
Perrigo Co PLCJsqqcqbmCmq$4.1 Bil
CURLF
Curaleaf Holdings IncSswgtxvqCnm$3.6 Bil
PBH
Prestige Consumer Healthcare IncLyhmmjdMztddf$3.5 Bil

Sponsor Center